Antibodies
Catalogue No. |
Name |
Application/Details |
Specificity |
MAB12422-100 |
Mouse Anti SARS-CoV-2 Spike (S1) Antibody (CR3022), Human IgG1 |
The original monoclonal antibody was generated by collecting peripheral blood lymphocytes of a patient exposed to the SARS-CoV. |
Target Antigen: SARS-CoV-2 (COVID-19) and SARS Coronavirus. |
MAB12423-50 |
Mouse Anti SARS-CoV-2 Spike (S1) Antibody (CR3022), Human IgM |
The original monoclonal antibody was generated by collecting peripheral blood lymphocytes of a patient exposed to the SARS-CoV. |
Target Antigen: Spike protein S1 |
200-401-A50 |
Rabbit anti-Sars Nucleocapsid Protein Antibody [Polyclonal] |
ELISA : 1:10,000 - 1:50,000
IF Microscopy : User Optimized
Western Blot : 1:2,000 - 1:10,000 |
This protein A purified antibody is directed against SARS Coronavirus Nucleocapsid (N) protein. As seen in Nature Research Journal |
200-401-MS9-0.5 |
Anti-SARS-CoV-2 Whole Spike Protein (RABBIT) Antibody |
ELISA, Western Blot |
This protein A purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a purified SARS-CoV-2 S protein with His-tag, derived from the transfected human HEK293 cells. |
100-401-A53 |
Anti-SARS-CoV Nonstructural Protein 8 (nsp8) (RABBIT) Antibody |
Immunoprecipitation, Western Blot |
This whole rabbit serum was produced by repeated immunizations with a purified His- tagged recombinant protein corresponding to full-length SARS-Coronavirus nsp8. |
HM1056 |
Coronavirus (MERS & SARS-CoV NP) Antibody |
ELISA, IFA |
MERS & SARS Coronavirus Nucleoprotein (NP) |
HM1059L |
Coronavirus (SARS-CoV E2) Antibody |
ELISA, WB |
Human Coronavirus |
HM1060L |
Coronavirus (SARS-CoV Membrane) Antibody |
ELISA, WB |
Human Coronavirus |
HM1054 |
Coronavirus (SARS-CoV NP) Antibody |
ELISA, WB, IFA |
SARS Coronavirus Nucleoprotein (NP) |
100531 |
Anti-hCoV OC43 3504 SPTN-5 |
|
Antibody recognizes human coronaviruses OC43 nucleoprotein and HKU1 |
ARG41099 |
Anti-ACE2 antibody |
IHC-P, IP, WB |
Human, Mouse, Rat |
ARG10284 |
Anti-Coronavirus antibody [Clone 5A4] |
ELISA |
|
ARG11092 |
Anti-SARS-CoV Spike protein antibody [1A9] |
Western Blot, Flow Cytometry |
reacts to spike proteins from SARS-CoV, SARS-CoV-2 (2019-nCoV), Civet SARS-CoV SZ3 strain, bat SL-CoV Rp3 and Rf1 |
Antigens
Catalogue No. |
Name |
Application |
Comments |
3620-1 |
Peptide pool for quantification of cytokine secreting cells specific for SARS-CoV-2 S2 and N proteins. |
Recommended for quantification of the number of cytokine secreting T cells specific for SARS-Cov-S2 and N proteins with ELISpot/Fluorospot. |
The SARS-CoV-2 derived T-cell epitopes were defined with the help of T-cell assays or from positive MHC binding assays (Ahmed SF., et al.). Based on these assays this peptide pool covers the following MHC alleles: HLA-A*01:01, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01, HLA-A*23:01, HLA-A*24:02, HLA-A*31:01, HLA-A*68:01, HLA-B*07:02, HLA-B*15:01, HLA-B*27:05, HLA-B*35:01, HLA-B*40, HLA-B*51:01, HLA-DRB1*01:01, and HLA-DRB1*04:01. |
HP811-60 NEW! |
Recombinant COVID-19 spike antigen (RBD) |
Suitable to use in ELISA, CLIA, CMIA and Rapid Test (POCT). |
Suggested indirect methods for IgG and IgM detection and sandwich methods for antibodies detection. |
HP811-08 NEW! |
Recombinant COVID-19 nucleocapsid antigen BA232 |
Suitable to use in ELISA, CLIA, CMIA and Rapid Test (POCT). |
Suggested indirect methods for IgG and IgM detection and sandwich methods for antibodies detection. |
HP811-04 NEW! |
Recombinant COVID-19 nucleocapsid antigen KA203 |
Suitable to use in ELISA, CLIA, CMIA and Rapid Test (POCT). |
Suggested indirect methods for IgG and IgM detection and sandwich methods for antibodies detection. |
HA811-12H NEW! |
Recombinant humanized anti-covid -19 Nucleocapsid protein IgG positive control |
Suitable to use in ELISA, CLIA, CMIA and Rapid Test (POCT). |
The product is intended for in vitro diagnostic use in the quality control of serum on clinical chemistry and immunoassay systems. |
LA557 |
Coronavirus (CoV-NP 229E) Antigen, Recombinant >95% |
ELISA, IgG/IgM detection |
Peptide composed of 359 amino acids containing immunodominant regions. |
LA570 |
Coronavirus (SARS-CoV ENV; 1-76) Antigen, Recombinant >90% |
ELISA, IgG/IgM detection |
Peptide composed of amino acids 1-76 of envelope protein. |
LA564L |
Coronavirus (SARS-CoV NP) Antigen, Recombinant >95% |
ELISA, WB |
Peptide composed of 422 amino acids of nucleoprotein. MW= 48 kDa |
REC31807 |
Novel Coronavirus (2019-nCoV) Spike Glycoprotein (S2), Sheep Fc-Tag (HEK293) |
SDS-PAGE |
is a recombinant antigen which contains the Spike subunit 2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-translational modifications. |
REC31806 |
Novel Coronavirus (2019-nCoV) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) |
SDS-PAGE |
is a recombinant antigen which contains amino acids 1-674 of subunit 1. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-translational modifications. |
PHOENIXDX® 2019-NCOV is a real-time RT-PCR-based detection system for the 2019 Wuhan coronavirus (2019-nCoV) with New FDA Approval. 2019-nCoV is considered a novel human coronavirus that is genetically distinct from the common human coronaviruses (229E, NL63, OC43, HKU1), which cause seasonal acute respiratory illness. It is also genetically distinct from the two newer human coronaviruses, MERS-CoV and SARS-CoV.
PHOENIXDX® 2019-NCOV detects the presence of 3 different and highly specific gene sequences of 2019-nCoV: E gene, N gene and RdRP gene. All 3 assays must be tested positive to confirm the sample as 2019-nCoV-positive.
Additionally, a non-infectious positive control and a negative human extraction control are included. The positive control is used to confirm functionality of the assays and overall PCR performance, the negative human extraction control is included to evaluate the quality of the RNA isolation independently from the 2019-nCoV assays.
NEW! PHOENIXDX® SARS-COV-2 MUTANT SCREEN [N501Y] is a real-time RT-PCR-based diagnostic test for the in vitro discrimination between wildtype SARS-CoV-2 and N501Y mutant SARS-CoV-2 in respiratory specimens and sera. The kit is intended to detect the N501Y mutation in samples already tested positive for SARS-CoV-2.
Enquire now at Sales@2BScientific.com
Diagnostic Kits
SKU |
Product Name |
Details |
BZL-17043.T0010 |
CORONA Rapid Test IgG and IgM CE-IVD |
Immunological rapid test for the qualitative detection of IgG and IgM antibodies against SARS-CoV2 |
BZL-243001N-10 |
NADAL[R] COVID-19 IgG/IgM Test |
10 test cassettes per package Detection of: COVID-19 IgG/IgM Rehearsals: Whole blood/serum/plasma, Qualitative determination From contents per package: 10 test cassettes, 10 pipettes, 1 buffer |
ELISA Kits
Catalogue No. |
Name |
Suitability |
CSB-EL33241HU NEW! |
Human Novel Coronavirus Spike Glycoprotein RBD (SARS-CoV-2 S RBD) IgG Antibody ELISA Kit |
This assay has high sensitivity and excellent specificity for detection of human SARS-CoV-2 S1 RBD IgG antibody. No significant cross-reactivity or interference between human SARS-CoV-2 S1 RBD IgG antibody and analogues was observed. |
CSB-EL3326HU NEW! |
Human Novel Coronavirus Nucleoprotein/Spike Glycoprotein S1 (SARS-CoV-2 N/S1) IgG Antibody ELISA Ki |
This assay has high sensitivity and excellent specificity for detection of human SARS-CoV-2 N/ S1 IgG antibody. No significant cross-reactivity or interference between human SARS-CoV-2 N/ S1 IgG antibody and analogues was observed |
CSB-EL33242HU NEW! |
Human Novel Coronavirus Spike Glycoprotein RBD (SARS-CoV-2 S RBD) IgM Antibody ELISA Kit |
This assay has high sensitivity and excellent specificity for detection of human SARS-CoV-2 S1 RBD IgM antibody. No significant cross-reactivity or interference between human SARS-CoV-2 S1 RBD IgM antibody and analogues was observed. |
CSB-EL33243HU NEW! |
Human Novel Coronavirus (SARS-CoV-2 ) Neutralizing Antibody ELISA Kit |
This assay has high sensitivity and excellent specificity for detection of SARS-CoV-2 neutralizing antibody. |
RV-405200 |
Human Anti-SARS-CoV-2 Virus (COVID-19) Spike 1 IgG ELISA Kit |
an immunoassay suitable for quantifying IgG antibody activity specific for S1 subunit of the spike protein of the SARS-CoV-2 virus, etiologic agent for the COVID-19 respiratory disease, in serum or plasma of vaccinated, immunized and/or infected hosts. |
AE-300700-1 |
RecombiVirus Mouse Hepatitis virus (MHV/Coronavirs) IgG ELISA Kit, 96 tests |
for detecting and quantifying IgG antibody activity specific for MHV spike glycoprotein (MVH-S) in serum or plasma. |
RV-402300-1 |
Recombivirus Human Anti-Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike protein 2 (S2) antibody (IgG) ELISA kit, 96 tests, Quantitative |
an indirect ELISA suitable for quantifying IgG antibody activity for MERS-S2 protein in human serum, plasma or other qualified biological samples from vaccinated, immunized and/or infected hosts. |
RV-402400-1 |
Recombivirus Human Anti-Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike protein 1 RBD (S1-RBD) antibody (IgG) ELISA kit, 96 tests, Quantitative |
An indirect ELISA suitable for quantifying IgG antibody activity for MERS Receptor-Binding Protein (RBD) in human serum, plasma or other qualified biological samples from vaccinated, immunized and/or infected hosts |
ARG80959 |
Human ACE2 ELISA Kit |
ARG80959 Human ACE2 ELISA Kit is an Enzyme Immunoassay kit for the quantification of Human ACE2 in serum, plasma, body fluids, tissue lysate or cell culture supernatant. |
E-HD-C044 |
Human Corona Virus Disease 2019 (COVID-19) IgG/IgM Lateral Flow Assay Kit |
Is a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies specific to COVID-19 in human whole blood, serum or plasma as an aid in the scientific research of primary and secondary COVID-19 infections |
Proteins
Molecule |
Cat. No. |
Species |
Host |
Product Description |
ACE2 protein |
AC2-H82E6 |
Human |
HEK293 |
Biotinylated Human ACE2 / ACEH Protein, His,Avitag™ |
AC2-H52H8 |
Human |
HEK293 |
Human ACE2 / ACEH Protein, His Tag |
AC2-H82F9 |
Human |
HEK293 |
Biotinylated Human ACE2 / ACEH Protein, Fc,Avitag™ |
AC2-C52H7 |
Cynomolgus |
HEK293 |
Cynomolgus ACE2 / ACEH Protein, His Tag |
AC2-R5246 |
Rat |
HEK293 |
Rat ACE2, His Tag |
AC2-M5248 |
Mouse |
HEK293 |
Mouse ACE2, His Tag |
S Protein |
SPN-C52H4 |
2019-nCoV |
HEK293 |
2019-nCoV S protein Full Length (R683A, R685A), His Tag |
SPN-S52H5 |
SARS |
HEK293 |
SARS S protein Full Length (R667A), His Tag |
S1 Protein |
S1N-C52H3 |
2019-nCoV |
HEK293 |
2019-nCoV S1 protein, His Tag |
S1N-C82E8 |
2019-nCoV |
HEK293 |
Biotinylated 2019-nCoV S1 protein, His,Avitag™ |
S1N-S52H5 |
SARS |
HEK293 |
SARS S1 protein, His Tag |
S Protein RBD |
SPD-C82E9 |
2019-nCoV |
HEK293 |
Biotinylated 2019-nCoV S protein RBD, His,Avitag™ |
SPD-C5255 |
2019-nCoV |
HEK293 |
2019-nCoV S protein RBD, Fc Tag |
SPD-S52H6 |
SARS |
HEK293 |
SARS S protein RBD, His Tag |
3CL-Mpro |
3CO-C51H5 |
2019-nCoV |
E.coli |
2019-nCoV 3CL-Mpro Protein, His Tag |
Nucleocapsid Protein |
NUN-C51H9 |
2019-nCoV |
E.coli |
2019-nCoV Envelope protein, His Tag |
Envelope Protein |
ENN-C5128 |
2019-nCoV |
E.coli |
2019-nCoV RNA-dependent RNA polymerase, His Tag |
RNA-dependant RNA Polymerase |
RNE-C5143 |
2019-nCoV |
E.coli |
2019-nCoV RNA-dependent RNA polymerase, His Tag |
ReadyTag Antibodies
SKU |
Name |
Reported Applications |
Details |
RT0269 |
ReadyTag anti-6-His |
WB, IP, IF |
Equivalent to anti FLAG) Clone: AP1501 |
RT0268 |
ReadyTag anti-HA |
ELISA, WB, IP, IF |
The 12CA5 mAb recognizes the 9-amino acid sequence YPYDVPDYA, derived from influenza virus hemagglutinin (HA). HA is commonly added to proteins of interest using recombinant DNA technology. The HA tag can then be used for detection or purification of the tagged protein. |
RT0266 |
ReadyTag anti-6-His |
WB, IP, IF |
The 6-His mAb reacts with polyhistidine (6-His). Histidine tags are commonly added to proteins of interest using recombinant DNA technology. The histidine tag can then be used for detection or purification of the tagged protein. |
Recombinant Antibodies
Catalogue |
Name |
Details |
Application |
Ab01680-10.0 |
Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022] |
This antibody binds the amino acids 318-510 in the S1 domain of the SARS-CoV Spike protein as well as COVID-19 Spike protein. |
NTRL, ELISA |
Ab01680-15.0 |
Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022] |
This antibody binds the amino acids 318-510 in the S1 domain of the SARS-CoV Spike protein as well as SARS-CoV-2 (COVID-19) Spike protein. The antibody also binds to P462L-substituted S318–510 fragments of the SARS spike protein. The binding epitope is only accessible in the "open" confromation of the spike protein (Joyce et al. 2020) |
This antibody has been attributed a potential to be developed as a therapeutic agent, alone or in combination with other neutralizing antibodies for treatment of 2019-nCoV infections (Tian et al., 2020). |
MHVS15-R-10 |
Recombinant (E. coli) Hepatitis virus (MHV/Coronavirs) Spike Protein S1 (>95% pure, His-tag, ~63 kda) |
MHV-S1 protein was expressed in E. Coli as histag fusion protein (extracellular domain, purity >95%, ~45 KDa). Purified protein is supplied in 50 mM Tris, pH 8, 0.25M NaCl, 5mM betamercaptoethanol,, 0.5mM ETDA, 0.25M imidzazole, and 8M Urea |
Western Blotting: load 100-200 ng/well. ELISA (50-100 ng antigen/well). |
TGEVS15-R-10 |
Recombinant (E.coli) Transmissible Gastroenteritis Coronavirus (TGEV)-S1 protein (>95%) |
Recombinant TGEV-S1 was expressed in E.coli as a his-tag fusion protein (776 aa, >95%, ~84.9 kDa). Purified protein is supplied in 16.7mM Tris-HCl, 2M G-HCl, 0.17 mM EDTA, 1.7mM β-mercaptoethanol, 0.08M NaCl and 0.08M Imidazole |
ELISA, Western blot Cellular Activity, Histochemistry & Immunofluorescence |
BCNP15-R-10 |
Recombinant (E.coli) Bovine Coronavirus (BCoV/BCV) nucleocapsid protein (GST-tag/His-tag, >95%) |
Recombinant Bovine Coronavirus nucleocapsid protein was expressed in E.coli as a his-tag fusion protein (448 aa, >95%, ~78 kda). Purified protein is supplied in 50mM Tris-HCl, 0.5 mM EDTA, 5mM βmercaptoethanol, 0.25M NaCl, 8M Urea, and 0.25M Imidazole |
ELISA, Western blot Cellular Activity, Histochemistry & Immunofluorescence |
Small Molecules
SKU |
Name |
Primary Activity |
COVID-19 Rationale |
10-1379 |
Hydroxychloroquine sulfate |
Autophagy inhibitor |
In clinical trials (alongside chloroquine) for SARS-CoV-2 infection |
10-2473 |
Chloroquine phosphate |
Autophagy inhibitor |
Sigma 1 receptor binder (SARS-CoV-2 Nsp6 protein interacts with the Sigma receptor) |
10-1009 |
Na Valproate |
HDAC inhibitor |
HDAC2 interacts with SARS-CoV-2 Nsp5 |
10-1062 |
Cycloheximide-N-ethylethanoate |
FKBP12 inhibitor |
mTORC1 pathway members interact with SARS-CoV-2 N and Orf8 proteins |
10-1089 |
Nafamostat mesylate |
Serine protease inhibitor |
Targets viral cell entry via inhibition of ACE2 |
10-1103 |
FK-506 |
FKBP inhibitor |
mTORC1 pathway members interact with SARS-CoV-2 N and Orf8 proteins |
10-1104 |
Rapamycin |
mTOR inhibitor |
mTORC1 pathway members interact with SARS-CoV-2 N and Orf8 proteins |
10-1105 |
PKC-412 (Midostaurin) |
Protein kinase inhibitor (pan specific) |
Inhibits MARK2/3, which interact with SARS-CoV-2 Orf9b |
10-1111 |
Verapamil |
L-type Ca2+ channel blocker |
Targets Multidrug resistance-associated protein 1 (MRP1), which interacts with SARS-CoV-2 Orf9c |
10-1281 |
Ribavirin |
Antiviral agent |
Inhibits IMPDH2, which interacts with SARS-CoV-2 Nsp14 |
10-1311 |
MLN4924 (Pevonedistat) |
Nedd8 activating enzyme inhibitor |
Targets Cullin2, which interacts with SARS-CoV-2 Orf10 |
10-1361 |
JQ1 |
Bromodomain inhibitor |
SARS-CoV-2 transmembrane protein E binds to the bromodomain-containing proteins BRD2 and BRD4 |
10-1458 |
GBR-12909 |
Dopamine reuptake inhibitor |
Sigma receptor agonist (SARS-CoV-2 Nsp6 protein interacts with the Sigma receptor) |
10-1569 |
Dabrafenib (GSK2118436) |
B-Raf mutant inhibitor |
Inibits NEK9, which interacts with SARS-CoV-2 Nsp9 |
10-2025 |
Entacapone |
COMT inhibitor |
COMT interacts with SARS-CoV-2 Nsp7 |
10-2057 |
Apicidin |
HDAC inhibitor |
HDAC2 interacts with SARS-CoV-2 Nsp5 |
10-2059 |
Ascomycin |
FKBP ligand |
mTORC1 pathway members interact with SARS-CoV-2 N and Orf8 proteins |
10-2253 |
Captopril |
ACE inhibitor |
Targets viral cell entry via inhibition of ACE2 |
is designed for rapid and effective isolation of RNA and DNA from a variety of pathogen organisms such as virus or bacteria. Samples can be fresh or frozen plasma/blood (treated with anticoagulants excepted heparin), serum, other cell-free body fluids or pathogen-infected tissue.
The Kit is specifically designed to isolate high-quality nucleic acids using low elution volumes and allowing sensitive downstream analysis including quantitative PCR and RT-PCR. The purified RNA/DNA is free of proteins and nucleases. Viral RNA+DNA Preparation Kit uses lysis buffer including chaotropic salts to inactivate RNases/DNases and advanced silica-gel membrane technology for fast purification of intact RNA/DNA. The preparation procedure is optimized to give reproducible results within 30 min.
Also RNase-free Water is suitable to experiment and research of RNA. The RNase-free Water, non DEPC, was prepared from highly purified water by ultrafiltration without DEPC treatment. The product was confirmed to be free from Rnase and Dnase.
Recommended Nucleic Acid Extraction Solution in Response to COVID-19 Crisis GF-1 Tissue Viral Nucleic Acid Extraction Kit / GF-1 Viral Nucleic Acid Extraction Kit
• Efficient viral lysis, denaturation of proteins and subsequent release of DNA or RNA
• Efficient recovery of highly pure DNA or RNA
• Purified DNA/RNA is suitable for downstream reactions, such as RT-qPCR and library prep for next generation sequencing
• Eliminates the need of toxic or organic-based extraction
• New protocols for use with different biological samples are being posted as they are developed. As an example, for guidance on the sample preparation of this kit with swabs, nasopharyngeal swab, saliva, sputum, bronchoalveolar lavage fluids, ascites. ORDERING INFO AT INFO@2BSCIENTIFIC.COM
Designing an Anti-Coronavirus Antibody ELISA?
If you need to prepare for mass production, what would be better than an ELISA plate blocker and stabilizer, which would save you time and resources.
WellChampion offers One blocking and stabilizing manufacturing step in 15 minutes.
As a customer says:
When using WellChampion, the coating, blocking and stabilization are all done in a single step, at room temperature, with no washes necessary. Based on my experience, when using this reagent in accordance to its manufacturer’s recommendations, one can expect a higher signal-to-noise ratio, a high reproducibility, in addition to an exceptionally fast and long-lasting coating. The only downside is that colleagues from other laboratories might ask for it.
Enquire at Info@2BScientific.com for further information
As a thank you for all our Research Colleagues doing incredible work in such times we would like to send a Covi-Shield with every order free of charge!